Sage Journals: Discover world-class research

Abstract

This article is an introduction to artificial intelligence (AI), especially the place of expert systems (ES) in AI. Some applications of expert systems in other industries are discussed, as well as potential areas of application within the pharmaceutical industry. Advantages and disadvantages of developing ES using so-called AI languages v ES shells are covered. A product review is presented, including AI languages, induction ES shells, straightforward rule shells, and sophisticated ES development environments. Also included is a discussion of the problems and pitfalls that may await anyone attempting to develop ES in pharmaceutical R&D. Finally, some recommendations are offered that they may be useful to those just getting started in this area.

Keywords

Artificial intelligence Expert systems Knowledge representation formalisms and methods Programming languages and software Learning

Get full access to this article

View all access options for this article.

References

Rich

: Artificial Intelligence. New York, McGraw-Hill, 1983.

Winston

Prendergast

: The AI Business: Commercial Uses of Artificial Intelligence. Cambridge, MA, MIT Press, 1986.

Barr

Feigenbaum

: The Handbook of Artificial Intelligence. Los Altos, CA, William Kaufmann, 1982.

Feigenbaum

McCorduck

: The Fifth Generation—Artificial Intelligence and Japan's Challenge to the World. Reading, MA, Addison-Wesley, 1983.

Brink

: Artificial Intelligence—Understanding the Impact of Knowledge. Columbus, Ohio, Battelle Memorial Institute, 1986.

Grevarter

: The nature and evaluation of commercial expert system building tools. IEEE Computer 1987; 20(5): 24–42.

Citrenbaum

Geissman

Schultz

: Selecting a shell. AI Expert 1987; 2(9): 30–39.

Freedman

: 27 Product wrapup: Evaluating shells. AI Expert 1987; 2(9): 69–74.

Expert Systems in the Pharmaceutical Industry

Abstract

Keywords

Get full access to this article

References